Facebook LinkedIn Twitter RSS Feeds January 9, 2017 at 12:00 AM EST Back Sanofi and Regeneron Provide Update on Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection Statement 1.9.17 Sanofi and Regeneron Provide Update on Ongoing Patent Litigation Regarding Praluent.pdf 95.1 KB
Statement 1.9.17 Sanofi and Regeneron Provide Update on Ongoing Patent Litigation Regarding Praluent.pdf 95.1 KB